首页|初发多发性骨髓瘤患者骨髓活检病理形态学分析及IFI16表达的临床意义

初发多发性骨髓瘤患者骨髓活检病理形态学分析及IFI16表达的临床意义

扫码查看
目的 探究初发多发性骨髓瘤(MM)患者骨髓活检病理形态学分析及干扰素诱导蛋白16(IFI16)表达的临床意义.方法 108例初发MM患者均行病理形态学分析,检测IFI16表达水平.使用Logistic及ROC分析骨髓活检病理形态学结果及预后影响因素.结果 106例MM患者增殖模式分型结节型占比最多,成熟度分型Ⅰ型占比最多;预后不良组年龄≥60岁占比、诊断到治疗时间≥3个月占比、ISS分期Ⅲ期占比、成熟度Ⅲ型占比、弥漫型占比及IFI16高表达占比均高于预后良好组,Logistic显示除诊断到治疗时间≥3个月外,其余均为MM的独立危险因素(P<0.05);ROC显示病理形态学联合IFI16预测MM预后的AUC高于单独预测.结论 初发MM患者病理形态学中成熟度Ⅲ型、弥漫型及IFI16高表达MM患者预后不良.
Clinical significance of bone marrow biopsy and IFI16 expression in patients with primary multiple myeloma
Objective To investigate the clinical significance of bone marrow biopsy pathologic analysis and interferon-induced protein 16(IFI16)expression in patients with primary multiple myeloma(MM).Methods The expression level of IFI16 was detected by pathologic analysis in 108 patients with initial onset of MM.The pathologic result and prognostic factors of bone marrow biopsy were analyzed by Logistic and ROC.Results In 106 MM patients,the number of proliferative model types was the highest,and the number of maturity type I was the highest.The proportion of age ≥60 years in the poor prognosis group,the proportion of time from diagnosis to treatment ≥ 3 months,the proportion of ISS stageⅢ,the proportion of maturity type Ⅲ,the proportion of diffuse type and the proportion of IFI16 high expression in the poor prognosis group were higher than those in the good prognosis group.Logistic analysis showed that except for ≥ 3 months from diagnosis to treatment,all the other risk factors were independent of MM(P<0.05).ROC showed that the AUC predicted by the combination of histopathology and IFI16 was higher than that predicted by alone.Conclusion In the pathology of initial onset of MM,patients with maturity type Ⅲ,diffuse type and high expression of IFI16 have poor prognosis.

Multiple myelomaPathologic analysisInterferon-induced protein 16Prognosis

畅立铭、王全红、王冠宙

展开 >

山西省运城市中医医院病理科,山西运城 044000

山西省白求恩医院病理科,太原 030000

山西省运城市中医医院血液科,山西运城 044000

多发性骨髓瘤 病理形态学分析 干扰素诱导蛋白16 预后

2024

诊断病理学杂志
北京军区总医院

诊断病理学杂志

CSTPCD
影响因子:0.663
ISSN:1007-8096
年,卷(期):2024.31(2)
  • 17